Hematology and Medical Oncology


Findings from the LAURA Phase III trial — presented at the ASCO Annual Meeting by Winship Executive Director Suresh Ramalingam, MD, and simultaneously published in The New England Journal of Medicine — show osimertinib significantly extends the time patients live without their cancer worsening, offering the first effective therapy and new hope for those with advanced EGFR-mutated non-small cell lung cancer.

President Biden has appointed Edjah K. Nduom, MD, to the National Cancer Advisory Board.

Discover how Emory is advancing health care and academic excellence through the responsible use of AI.


Loading Events...